Notably, shRNA-mediated knockdown of FOXA1 and FOXA2, along with sustained ETS1 expression, completely shifted HCC to intrahepatic cholangiocarcinoma development in primary liver cancer mouse models [22]. Here, FOXA2 is linked to liver cancer.